IMAGING GLIOBLASTOMA PROGRESSION DURING ANTI-VEGF THERAPY

被引:0
|
作者
Barajas, Ramon [1 ]
Chang, Jamic [1 ]
Sneed, Patricia [1 ]
Medermott, Michael [1 ]
Cha, Soonmee [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:896 / 896
页数:1
相关论文
共 50 条
  • [21] Patterns of Progression in Malignant Glioma Following Anti-VEGF Therapy: Perceptions and Evidence
    Wick, Wolfgang
    Wick, Antje
    Weiler, Markus
    Weller, Michael
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (03) : 305 - 312
  • [22] Anti-VEGF Therapy and the Retina: An Update
    Tah, Vikas
    Orlans, Harry O.
    Hyer, Jonathan
    Casswell, Edward
    Din, Nizar
    Shanmuganathan, Vishnu Sri
    Ramskold, Louise
    Pasu, Saruban
    JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [23] Tumor refractoriness to anti-VEGF therapy
    Ribatti, Domenico
    ONCOTARGET, 2016, 7 (29) : 46668 - 46677
  • [24] Anti-VEGF Therapy in Myopic CNV
    Toto, Lisa
    Di Antonio, Luca
    Costantino, Olivia
    Mastropasqua, Rodolfo
    CURRENT DRUG TARGETS, 2021, 22 (09) : 1054 - 1063
  • [25] Anti-VEGF therapy in pituitary carcinoma
    Leon D. Ortiz
    Luis V. Syro
    Bernd W. Scheithauer
    Ayca Ersen
    Humberto Uribe
    Camilo E. Fadul
    Fabio Rotondo
    Eva Horvath
    Kalman Kovacs
    Pituitary, 2012, 15 : 445 - 449
  • [26] Pharmacological basis of the anti-VEGF therapy
    Schmetterer, Leopold
    Garhoefer, Gerhard
    SPEKTRUM DER AUGENHEILKUNDE, 2012, 26 (04) : 185 - 196
  • [27] Chances and risks of anti-VEGF therapy
    Ziemssen, F.
    Heiduschka, P.
    Peters, S.
    Grisanti, S.
    Schraermeyer, U.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2008, 225 (09) : 770 - 778
  • [28] Disappointing outcomes for anti-VEGF therapy
    Lisa Richards
    Nature Reviews Clinical Oncology, 2011, 8 (4) : 194 - 194
  • [29] Anti-PD-1, anti-VEGF, and temozolomide therapy in a patient with recurrent glioblastoma: a case report
    Chen, Can
    Zuo, Wenwei
    Yang, Pan
    Zhang, Yanling
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (09)
  • [30] Anti-VEGF als Adjuvans bei Morbus CoatsAdjuvant anti-VEGF therapy in Coats’ disease
    M. Fiorentzis
    E. Stavridis
    B. Seitz
    A. Viestenz
    Der Ophthalmologe, 2015, 112 : 451 - 454